Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma

17 Feb 2021

Abstract excerpt

COVID-19 pandemic has led to an unprecedented need to develop an effective and safe vaccine in a timely manner. SARS-CoV-2 binds to human cells via the spike (S) protein, which targets the cellular angiotensin-converting enzyme (ACE-2) expressed on their surface. The identification of the S protein has led to two categories of vaccines with different mechanisms of action that target this protein. The first one...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to COVID-19 Impact on Reproduction
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33623886
DOI: 10.1097/hs9.0000000000000547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Vaccines in Patients With Multiple MyelomaPMID 33623886Read ↗

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerSemantic proximity Read ↗

Preclinical Study of DNA Vaccines Targeting SARS-CoV-2Semantic proximity Read ↗

Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort StudySemantic proximity Read ↗

Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort StudySemantic proximity Read ↗

Loss of Anti-Spike Antibodies Following mRNA Vaccination for COVID-19 Among Patients with Multiple MyelomaSemantic proximity Read ↗

Covid-19 vaccination in patients with multiple myeloma: Focus on immune response.Semantic proximity Read ↗

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myelomaSemantic proximity Read ↗

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patientsSemantic proximity Read ↗

The Effectiveness of Bivalent mRNA Omicron Containing Booster Vaccines Among Patients with Hematological NeoplasmsSemantic proximity Read ↗

Fatal breakthrough infection after anti-BCMA CAR-T therapy highlights suboptimal immune response to SARS-CoV-2 vaccination in myeloma patientsSemantic proximity Read ↗

Cellular Mechanisms Associated with Sub-Optimal Immune Responses to SARS-CoV-2 Bivalent Booster Vaccination in Patients with Multiple MyelomaSemantic proximity Read ↗

Dual roles of a novel oncolytic viral vector-based SARS-CoV-2 vaccine: preventing COVID-19 and treating tumor progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.